arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Theravance Biopharma, Inc.

TBPH Health Care Biotechnology: Pharmaceutical Preparations
$16.29
▼ -0.5% Today
as of Jun 7, 07:29 ET
Last 30 days -2.80% Apr 28 → Jun 05
$15.46 $15.88 $16.30 $16.72 $17.14 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$16.44
High
$16.65
Low
$16.28
Volume
$233,201
Avg Vol
$448,080
Mkt Cap
$836M
P/E (TTM)
15.51
Beta
52w High
$21.03
52w Low
$10.42
Div Yield
Shares Out
$52M

Overview

52-week range
$10
$21
55% of range
Avg surprise (last 2)
-1.9%
Avg reaction (last 2)
-0.2%
50% positive
Latest IV / EM
230%
EM ±31.9% · $18 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.34$0.02$0.37$0.73$1.08 Actual $-0.28Actual $-0.17Actual $-0.24Actual $-0.34Actual $-0.26Actual $-0.27Est $-0.26Actual $1.08Actual $0.07Actual $-0.06Est $-0.06 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-17M$2M$21M$39M$58M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.06 $-0.06 0.0% +77.8% +0.5% earnings
Tue Sep 30, 2025Sep 2025 $0.07 financials
Mon Jun 30, 2025Jun 2025 $1.08 financials
Thu May 8, 2025Mar/2025 $-0.27 $-0.26 -3.9% -0.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.26 financials
Sun Jun 30, 2024Jun 2024 $-0.34 financials
Sun Mar 31, 2024Mar 2024 $-0.24 financials
Sat Sep 30, 2023Sep 2023 $-0.17 financials
Fri Jun 30, 2023Jun 2023 $-0.28 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-9M$-6M$-3M$-14M$-11M$-16M
Net income$-5M$4M$55M$-14M$-13M$-17M
EPS (diluted)$-0.10$0.07$1.08$-0.27$-0.26$-0.34

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$288M$168M$175M$282M$111M$38M$23M$46M
Inventory
Total current assets$418M$418M$355M$366M$150M$161M$116M$119M
Total assets$472M$486M$415M$426M$344M$354M$356M$362M
Long-term debt
Total liabilities
Total equity$291M$297M$233M$225M$166M$176M$186M$194M

Implied volatility — last 90 days

225%227%230%232%235% Jun 07 — IV 230% · EM ±31.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.